International Cannabis Weekly: 433

FRANCE EXTENDS MEDICAL CANNABIS ACCESS AGAIN AS FULL ACCESS BILL REMAINS STUCK IN LIMBO

Thousands of French medical cannabis patients will continue to receive their treatment for the foreseeable future, as the highly anticipated full generalised framework edges towards reality.

READ MORE  »

RELM AND PROHIBITION PARTNERS LAUNCH CANNABIS RISK BRIEFING

READ MORE »

CANNATREK IN REVERSE TAKEOVER OF LITTLE GREEN PHARMA TO TACKLE EUROPE

READ MORE »

• Somai and Universidade Lusófona publish peer reviewed study on batch consistency method for cannabis oils.
• Inside medical cannabis police guidance covering Cancard driving rules and patient rights.
• Portugal has spent more than three million euros on Epidyolex as reimbursement review drags on.
• The battle for Germany’s medial cannabis market: Who is fighting for what in new debate.
• Assessing Village Farms International valuation as cannabis and produce businesses diverge.
• Annabis launches new CBD and CBG oil bundle targeting European wellness consumers.
• Maastricht plans relocation of cannabis coffeeshop boats along Maasboulevard waterfront.
• Germany’s medical cannabis system faces strain as falling prices drive explosive prescription growth.

SEE FULL DETAILS»

• Advocates push for sensible cannabis legislation as new legislative session opens.
• UCLA awarded major state funding to advance comprehensive cannabis research programme.
• Three in five Indiana residents support cannabis legalisation as lawmakers file reform bills.
• US cannabis sales decline in 2025 despite record breaking performance in December.
• Terplandia reclaims independent ownership and relaunches cannabis derived terpene platform.
• Governor Murphy signs landmark cannabis worker protections into law in New Jersey.
• Alabama doctors can now apply for medical cannabis permits as dispensary cities confirmed.
• Hawaii cannabis expo returns to Honolulu with educational speakers and industry exhibits.

• SNDL acquires five cannabis dispensaries across Alberta and Saskatchewan from 1CM.
• Majority of British Columbia residents support cannabis legalisation but oppose other drugs.
• Canada sees no increase in youth cannabis use following legalisation new data shows.
• Auxly reviews 2025 milestones and outlines strategic priorities for 2026 growth.
• Glow Lifetech expands into medical cannabis channel with national Mendo Medical launch.
• Avant Brands has adopted a shareholder rights plan to protect long term corporate value.
• High Tide is poised to announce its fourth quarter as well as its full year 2025 financial results.
• Data indicates there has been no increase in youth cannabis use post legalisation.

• MediPharm Labs to enter Costa Rica cannabis market through new supply agreement.
• Medical cannabis import flow experiences delays across Brazil amid regulatory bottlenecks.

• Argent secures CannPal Animal Therapeutics stake in restructured Auscann transaction. 
• Gelteq preclinical results show increased absorption of medicinal cannabinoid formulations.
• More speakers added to UIC conference line up with discounts for Cannabiz members.
• Cannabis activists in Bangkok are demanding political parties clarify their stance.

• High Times argues legal weed failed to fix South Africa’s entrenched cannabis problems.
• Retailers included in new cannabis tax regime with annual development fund levy.